普蕊斯(301257) - 301257普蕊斯投资者关系活动记录表20260313
ClinPlusClinPlus(SZ:301257)2026-03-13 11:36

Company Overview - Proris is a data-driven clinical research service provider focused on patient-centered approaches, creating a comprehensive project management system for clinical trials [1] - The company has established a nationwide network of clinical trial institutions, serving over 960 clinical trial institutions and covering more than 1,300 sites [2] - As of June 2025, Proris has undertaken over 4,200 international and domestic clinical projects, with 2,538 active projects [3] Industry Trends - In 2025, the number of drug clinical trials registered in China reached 5,173, a year-on-year increase of 6.44% [2] - The National Medical Products Administration approved 76 Class 1 innovative drugs, marking a 58% increase and a historical high [2] - China accounts for approximately 30% of the global pipeline of new drugs, ranking second worldwide [2] Financial Performance - Since its listing, Proris has distributed a total of CNY 46.1455 million in cash dividends to shareholders, emphasizing its commitment to shareholder returns [2] Competitive Advantages - The company has strong competitive advantages in various therapeutic areas, including hematologic tumors, thoracic tumors, digestive tumors, and rare diseases [3] - Proris is positioned as a key link between the research and clinical ends of the pharmaceutical innovation ecosystem, enhancing the efficiency and quality of new drug development in China [3] Quality Management - Proris has undergone 281 inspections by national and provincial authorities, 14 by the FDA, and 5 by the EMA, with no major findings reported [4] - The company has established a systematic quality management framework, including over 280 standard operating procedures (SOPs) to ensure compliance and quality [4] Recruitment and Training - The recruitment plan is based on existing and new project needs, with a focus on optimizing the recruitment structure to adapt to market demands and regulatory standards [5] - Proris emphasizes a robust training system to enhance employee skills and ensure high-quality service delivery [5]

ClinPlus-普蕊斯(301257) - 301257普蕊斯投资者关系活动记录表20260313 - Reportify